Asensus surgical announces $10 million registered direct offering

Research triangle park, n.c., july 27, 2023 (globe newswire) -- asensus surgical, inc. (nyse american: asxc) (“asensus” or the “company”), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of performance-guided surgery™, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 23,809,524 shares of its common stock and warrants to purchase 23,809,524 shares of common stock in a registered direct offering. the shares of common stock and accompanying warrants are being sold at a combined purchase price of $0.42 per share and accompanying warrant to purchase one share of common stock. the warrants have an exercise price of $0.42 per share, are immediately exercisable and will expire five years following the date of issuance. the offering is expected to close on or about july 31, 2023, subject to the satisfaction of customary closing conditions.
ASXC Ratings Summary
ASXC Quant Ranking